PHYTOCHEM REMEDIES IPO
Quick Overview for Investors
| IPO Period | 18th – 22nd December 2025 |
|---|---|
| Listing on | 26th December 2025 |
| Price Band | ₹98 per equity share |
| Lot Size & Minimum Investment | 1200 shares (₹117,600) |
| Total Issue Size | ₹38.22 Crores |
Phytochem Remedies (India) Limited is set to launch its Initial Public Offering, offering an opportunity for investors to participate in a company specializing in corrugated packaging products. The IPO period runs from December 18th to December 22nd, 2025, with shares priced at ₹98 per equity share. Investors can subscribe in lots of 1200 shares, making the minimum investment ₹117,600. The entire issue comprises a fresh issue of shares, aiming to raise ₹38.22 Crores for various strategic initiatives.
Key Milestones and Timelines
- Opening Date: 18th December 2025
- Closing Date: 22nd December 2025
- UPI Payment Deadline: 22nd December 2025 (5 PM)
- Allotment Announcement: 23rd December 2025
- Refund Processing: 24th December 2025
- Demat Credit: 24th December 2025
- Stock Market Listing: 26th December 2025
- Mandate Validity End: 7th January 2026
- Anchor Investor Lock-in Release (50%): 22nd January 2026
- Anchor Investor Lock-in Release (Remaining): 22nd March 2026
*Dates may be revised as per official updates. Investors are advised to monitor official announcements for any changes.
Understanding Phytochem Remedies (India) Limited
Founded in 2002, Phytochem Remedies (India) Limited operates prominently in the packaging solutions sector, specializing in the manufacturing of high-quality corrugated packaging products. The company commenced its manufacturing operations in 2014 and has since established a strong foothold with two strategically located units in Bari Brahmana, Jammu. This operational setup offers significant logistical advantages and substantial capacity for future expansion, positioning the company favorably in its regional market.
Phytochem Remedies is led by its dedicated promoters, Niranjan Surana, Shilpa Surana, Aditi Bohra, and Bohra Agrifilms Private Limited. Their visionary leadership has been instrumental in guiding the company’s growth, modernization efforts, and consistent operational excellence. The company’s core product portfolio includes a diverse range of corrugated items such as boxes, rolls, sheets, and pads, all meticulously designed to meet the specific requirements of various industrial sectors.
The company serves a wide array of industries, including pharmaceuticals, agriculture, pesticides, automotive, and fast-moving consumer goods (FMCG), demonstrating its versatility and ability to cater to diverse packaging needs. Its robust production capabilities are anchored by both a semi-automatic production line and a state-of-the-art, fully automatic corrugated board plant, which was commissioned in 2022. Operating on a manufacturing-to-order model, Phytochem Remedies generates revenue by consistently delivering customized, durable, and cost-effective packaging solutions tailored to client specifications. With the growing demand for packaging across multiple sectors, Phytochem is well-positioned to capitalize on its operational strengths and expand its market presence.
IPO Funding and Capital Structure
| Total Funds Raised | ₹38.22 Crores |
|---|---|
| Fresh Issue Component | ₹38.22 Crores |
| Offer for Sale Component | Nil |
The entire IPO of Phytochem Remedies consists of a Fresh Issue of equity shares, meaning all proceeds from the offering will directly flow into the company. This influx of capital is earmarked for various strategic purposes aimed at strengthening the company’s operational capabilities, expanding its infrastructure, and enhancing its financial stability for sustained growth. By opting for a complete fresh issue, the company aims to fuel its expansion plans and achieve its long-term objectives without any shares being offered by existing shareholders.
Strategic Utilization of Capital
The capital raised through this IPO is intended to be deployed strategically across several key areas to support Phytochem Remedies’ growth trajectory and operational efficiency. The planned allocation ensures that funds are directed towards both immediate needs and long-term expansion initiatives.
| Objective | Amount (INR Crores) | Allocation % |
|---|---|---|
| Capital expenditure for equipment/machinery | 13.60 | 35.60% |
| Funding capital expenditure towards civil construction | 5.88 | 15.40% |
| Repayment / pre-payment of certain borrowings | 9.37 | 24.50% |
| Issue-related expenses | 3.73 | 9.80% |
| General corporate purposes | 5.64 | 14.80% |
A significant portion of the proceeds, 35.60%, is allocated to capital expenditure for new equipment and machinery, which is crucial for enhancing production capacity and adopting advanced manufacturing technologies. An additional 15.40% is earmarked for civil construction, further expanding the company’s physical infrastructure. Approximately a quarter of the funds (24.50%) will be utilized for the repayment or pre-payment of existing borrowings, which will help reduce financial leverage and strengthen the balance sheet. The remaining funds are allocated to cover issue-related expenses and for general corporate purposes, providing the company with operational flexibility.
Core Business Advantages
Phytochem Remedies boasts several competitive strengths that underpin its market position and potential for future growth:
- Strategic Manufacturing Presence: The company’s manufacturing facilities are strategically located in Jammu, offering logistical benefits and significant unutilized land for future expansion. This positioning enables efficient distribution and scalability.
- Diverse Product Portfolio: Phytochem offers a wide array of customized corrugated packaging solutions, catering to the specific needs of various industries. This diversification reduces reliance on any single sector and broadens its market reach.
- Modern Production Setup: The company operates with a modern production infrastructure, including a fully automatic corrugated board plant commissioned in 2022. This advanced setup ensures high-quality output, efficiency, and the ability to meet large-scale demands.
- Strong Regional Customer Base: Phytochem has cultivated a robust regional customer base, fostered through established long-term relationships. This loyal client network provides a stable revenue stream and opportunities for repeat business.
- Promoter-Led Company with Experience: The company benefits from experienced promoters who possess deep sector knowledge and a proven track record of consistent operational growth. Their leadership provides strategic direction and stability.
Key Considerations and Potential Challenges
While Phytochem Remedies presents compelling strengths, investors should also be aware of potential risks:
- High Customer Concentration: A significant portion of the company’s revenue is derived from its top clients. This high customer concentration could pose a risk if any major client reduces their business or switches suppliers.
- Dependence on Suppliers: The company heavily relies on suppliers for raw materials but currently lacks long-term agreements with them. This dependence could lead to price volatility or supply chain disruptions.
- Concentrated Manufacturing Facilities: All manufacturing facilities are located in Jammu. This geographical concentration exposes operations to potential regional risks, including natural disasters, political instability, or localized economic downturns.
- Outstanding Trade Receivables: Phytochem has significant outstanding trade receivables, indicating potential risks of delayed customer payments. This could impact the company’s working capital and liquidity.
- Past Negative Cash Flows: The company has experienced negative cash flows in past periods. This trend could indicate potential liquidity challenges and impact its ability to fund operations or expansion without external financing.
Tracking Investor Interest: Subscription Overview
As of 05:00 PM on December 19, 2025, the subscription statistics for the Phytochem Remedies IPO show the initial interest from various investor categories:
| Investor Category | Shares Reserved (Lakhs) | Shares Applied (Lakhs) | Subscription (Times) |
|---|---|---|---|
| Non-Institutional Investors (NII) | 18.51 | 3.68 | 0.20 |
| Retail Individual Investors (RII) | 18.51 | 5.01 | 0.27 |
| Total | 37.03 | 8.70 | 0.23 |
*Subscription figures reflect the interest as of the specified date and time. Exchange data provides reliable indicators of IPO interest. Grey Market Premium (GMP) figures are unofficial and may vary, hence exchange data is considered more dependable for assessing real-time demand.
Participating in the IPO
Investors keen on participating in the Phytochem Remedies IPO can easily do so through the official Dhan Kirti IPO platform. Ensure you complete your application before the subscription window closes on December 22nd, 2025. This opportunity allows you to potentially become a part-owner of a growing company in the essential packaging sector.
